ECL vs ISPC · P/E 35, rev $4.01B vs rev $9.3M
Ecolab Inc (ECL) versus iSpecimen Inc (ISPC) — a side-by-side from cached financials, not a winner call.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
ECL currently screens at market cap $72.05B and trailing P/E 34.6. ISPC currently screens at market cap $4.4M.
Not investment advice. Open the ECL and ISPC stock pages for the full models.
Not investment advice.